Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 141.75 EUR 2.49% Market Closed
Market Cap: 61.6B EUR
Have any thoughts about
Merck KGaA?
Write Note

Relative Value

The Relative Value of one MRK stock under the Base Case scenario is 190.06 EUR. Compared to the current market price of 141.75 EUR, Merck KGaA is Undervalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MRK Relative Value
Base Case
190.06 EUR
Undervaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
37
Median 3Y
3.4
Median 5Y
3.3
Industry
2.5
Forward
2.9
vs History
77
vs Industry
20
Median 3Y
23.8
Median 5Y
25.2
Industry
21.9
Forward
16.1
vs History
96
vs Industry
25
Median 3Y
17.4
Median 5Y
16.9
Industry
16.5
vs History
79
vs Industry
8
Median 3Y
49.5
Median 5Y
41.6
Industry
23.6
vs History
96
vs Industry
35
Median 3Y
2.7
Median 5Y
2.7
Industry
2.1
vs History
92
vs Industry
34
Median 3Y
3.7
Median 5Y
3.6
Industry
2.6
Forward
3
vs History
82
vs Industry
36
Median 3Y
6
Median 5Y
5.9
Industry
5.2
vs History
90
vs Industry
28
Median 3Y
12.9
Median 5Y
12.8
Industry
13.3
Forward
10.9
vs History
71
vs Industry
22
Median 3Y
18.7
Median 5Y
20.5
Industry
16.6
Forward
15.8
vs History
98
vs Industry
24
Median 3Y
19
Median 5Y
19
Industry
15.6
vs History
73
vs Industry
12
Median 3Y
33.8
Median 5Y
33.2
Industry
19.1
vs History
79
vs Industry
43
Median 3Y
1.8
Median 5Y
1.7
Industry
1.9

Multiples Across Competitors

MRK Competitors Multiples
Merck KGaA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Merck KGaA
XETRA:MRK
61.6B EUR 2.9 22.9 11.8 19
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
DE
Merck KGaA
XETRA:MRK
Average P/E: 31.2
22.9
64%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top